FDA releases Coronavirus Update

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the Coronavirus (COVID-19) pandemic:

The FDA announced that it is leading an effort, working collaboratively with government, industry and academic partners, to develop and implement a protocol that will provide convalescent plasma to patients in need across the country who may not have access to institutions with clinical trials in place. 

[Read more]

FDA Coronavirus (COVID-19) Update for April 3rd, 2020

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) continues to play a critical role in accelerating medical countermeasures to treat and prevent Coronavirus (COVID-19).

As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.

[Read more]

FDA releases Coronavirus Update, Daily Roundup

Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the coronavirus COVID-19 pandemic:

The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who have recovered from the coronavirus COVID-19 virus, that could shorten the length, or lessen the severity, of the illness.

[Read more]